Publications

Pour rechercher une publication scientifique, insérez vos mots-clés en anglais.
Salignon P Cabrol JC Liu J Legros D Brown V Ford N
Lancet (London, England) 2000 Nov 18; 356(9243); 1762. doi: 10.1016/S0140-6736(00)03217-7. Epub 2000 12 14

Epidemiology of cholera outbreak in Kampala, Uganda.

Abstract

OBJECTIVE: To provide epidemiological description of the cholera outbreak which occurred in Kampala between December 1997 and March 1998.

DESIGN: A four-month cross-sectional survey.

Legros D McCormick M Mugero C Skinnider M Bek'Obita DD Okware SI
East African medical journal 2000 Jul ; 77(7); 347-9. doi: . Epub 2003 08 15

Vaccination in emergencies.

Abstract

Nongovernmental organisations (NGOs) are the main actors of vaccine delivery during complex humanitarian emergencies such as large population displacements.

Paquet C
Vaccine 1999 Oct 29; 17 Suppl 3 S116-9. doi: . Epub 1999 12 30

Famine in southern Sudan.

Abstract

We provide baseline information and objective testimony on severe malnutrition and high mortality in the general population of southern Sudan that is affected by chronic civil war and severe famine.

Creusvaux H Brown V Lewis R Coudert K Baquet S
Lancet (London, England) 1999 Sep 04; 354(9181); 832. doi: 10.1016/S0140-6736(99)80016-6. Epub 1999 10 04

Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda.

Abstract

We evaluated the treatment failure rate among late-stage human African trypanosomiasis (HAT) patients treated with melarsoprol in Arua, northern Uganda, between September 1995 and August 1996, and identified the risk factors for treatment failure.

Legros D Evans S Maiso F Enyaru JC Mbulamberi D
Transactions of the Royal Society of Tropical Medicine and Hygiene ; 93(4); 439-42. doi: . Epub 2000 02 22

[Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].

Abstract

The failure rate of melarsoprol after treatment of late stage cases of Human African Trypanosomiasis (HAT) is usually under 7%, even though the drug has been used for such treatment over the past 50 years.

Legros D Fournier C Gastellu Etchegorry M Maiso F Szumilin E
Bulletin de la Societe de pathologie exotique (1990) 1999 Jul ; 92(3); 171-2. doi: . Epub 1999 10 06